QELBREE Trademark

Trademark Overview


On Monday, November 18, 2019, a trademark application was filed for QELBREE with the United States Patent and Trademark Office. The USPTO has given the QELBREE trademark a serial number of 88696469. The federal status of this trademark filing is REGISTERED as of Tuesday, November 16, 2021. This trademark is owned by Supernus Pharmaceuticals, Inc.. The QELBREE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
qelbree

General Information


Serial Number88696469
Word MarkQELBREE
Filing DateMonday, November 18, 2019
Status700 - REGISTERED
Status DateTuesday, November 16, 2021
Registration Number6563462
Registration DateTuesday, November 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 23, 2019
Primary Code005
First Use Anywhere DateMonday, May 24, 2021
First Use In Commerce DateMonday, May 24, 2021

Trademark Owner History


Party NameSupernus Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Tuesday, November 16, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, October 14, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 13, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 6, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 21, 2021USE AMENDMENT FILED
Monday, August 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 21, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021EXTENSION 1 GRANTED
Thursday, January 21, 2021EXTENSION 1 FILED
Thursday, January 21, 2021TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 6, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 22, 2020ASSIGNED TO LIE
Monday, April 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 13, 2020EXAMINER'S AMENDMENT ENTERED
Monday, April 13, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 13, 2020EXAMINERS AMENDMENT E-MAILED
Monday, April 13, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, February 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 28, 2020NON-FINAL ACTION E-MAILED
Friday, February 28, 2020NON-FINAL ACTION WRITTEN
Friday, February 21, 2020ASSIGNED TO EXAMINER
Saturday, November 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 21, 2019NEW APPLICATION ENTERED IN TRAM